Clinical trials
Digestive System Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
75 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 13 |
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 30 |
| Unknown status | 20 |
| Completed | 18 |
| Active, not recruiting | 4 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sichuan Baili Pharmaceutical Co., Ltd. | 8 |
| Shenzhen Hornetcorn Bio-technology Company, LTD | 4 |
| Fudan University | 3 |
| Sir Run Run Shaw Hospital | 3 |
| Creative Biosciences (Guangzhou) Co., Ltd. | 2 |
| Fujian Cancer Hospital | 2 |
| Jinling Hospital, China | 2 |
| Peking University | 2 |
| Peking University Cancer Hospital & Institute | 2 |
| Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Digestive System Neoplasms | 75 |
| Gastrointestinal Neoplasms | 20 |
| Neoplasms | 20 |
| Colorectal Neoplasms | 15 |
| Digestive System Diseases | 13 |
| Gastrointestinal Diseases | 13 |
| Neoplasms by Site | 12 |
| Intestinal Neoplasms | 10 |
| Carcinoma, Hepatocellular | 9 |
| Neoplasms by Histologic Type | 9 |
Trials
Showing 26 to 50 of 75. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.